In her article for Yahoo Life, Laura Hampson details a groundbreaking Harvard Medical School study published in the journal Cell that uncovered a direct biological trigger for random itching and chronic skin conditions.
Scientists discovered that random itching is often caused directly by Staphylococus aureus, a common bacterium found on human skin., particularly in people with conditions like eczema. Previously, medical experts believed that itching was Primarily a side effect of skin inflammation. However, this study demonstrated that the bacterium itself can trigger the urge to scratch independently of inflammation.
The researchers identified the exact molecular mechanism behind this reaction. S. aureus releases a specific bacterial enzyme called protease V8. When V8 comes into contact with the skin, it cleaves and activates a receptor called PAR1, located on sensory nerve fibers. Once PAR1 is activated, it sends a direct signal along the nerve pathway to the brain, which interprets the message as an intense itch.
This bacterial mechanism also triggers hypersensitivity to light touches, making normally harmless contact (like wearing a sweater) feel itchy- a phenomenon known as alloknesis. Scientists hypothesize that bacteria evolved to induce itching because scratching causes tiny skin tears that help the microbe spread and penetrate deeper tissue layers.
Crucially, the study pointed toward potential relief. Because PAR1 is also involved in blood clotting, researches tested an existing anti-clotting medication on mice and found it rapidly blocked the V8-par1 pathway, stopping the itch-scratch cycle and preventing skin damage. This discover paves the way for targeting skin microbes directly to formulate topicals and treatments for chronic itch
